Interview opportunity: JDRF celebrates the announcement of Dexcom G6 CGM System's Availability in Canada
JDRF shares the excitement of the type 1 diabetes community around today’s arrival of the Dexcom G6,” said Dave Prowten, President an...Read More
Sun Life Financial and the Canadian Football League (CFL) partner to raise up to $100,000 for JDRF
JDRF’s partner ViaCyte recently announced the U.S. Food and Drug Administration (FDA) is allowing them to move forward with a clinical trial of its innovative type 1 diabetes (T1D) encapsulated cell replacement therapy called VC-01™ product candidate.
JDRF Partner ViaCyte Announces Key Project Milestone to Advance Innovative Encapsulated Cell Replacement Therapy Product for Type 1 Diabetes
To address the need for education on how patients with type 1 diabetes (T1D) can pursue physical activity safely, Novo Nordisk has committed to a three-year, $5 million grant in support of a new JDRF Outreach initiative titled “T1D Performance in Exercise and Know...
JDRF and the Innovative Medicines Initiative (IMI) have partnered on a new precompetitive type 1 diabetes research consortium entitled “TRANSLATIONAL APPROACHES TO DISEASE MODIFYING THERAPY OF TYPE 1 DIABETES MELLITUS (T1DM)”.
On June 8, Canadians in approximately 70 cities across the nation will “Join the Community” as they take part in the 2014 TELUS Walk to Cure Diabetes and walk toward a cure for type 1 diabetes (T1D).
On Saturday, June 21, 2014, the fourth annual Barrie Waterfront Half Marathon, 10K & 5K is taking place throughout the streets of Barrie and along scenic Lake Simcoe. JDRF is once again honoured to be one of the six featured charities in this year&rsq...
From April 6 to 12, JDRF celebrates and recognizes the extraordinary contribution of our volunteers across Canada. This year’s theme is Thank You. This week is set aside each year to honour the extensive commitment and dedication our volunteers demonstrate through...
JDRF Applauds the Government of British Columbia for extending coverage of the insulin pump program to British Columbians living with type 1 diabetes
JDRF applauds the Government of British Columbia for extending coverage of the insulin pump program for eligible British Columbians aged 19 to 25 years old. Currently, British Columbia covers the costs of insulin pumps to anyone 18 years and younger who are living with type 1 diabetes (T1D...
JDRF Canadian Clinical Trial Network (JDRF CCTN) has announced the official launch of its expansion to western Canada through the generous support of the WB Family Foundation.